Immediate Hypersensitivity Reactions Caused by Drug Excipients: A Literature Review

Abstract

The European Medicines Agency defines excipients as the constituents of a pharmaceutical form apart from the active substance. Immediate hypersensitivity reactions (IHRs) caused by excipients contained in the formulation of medications have been described. However, there are no data on the prevalence of IHRs due to drug excipients. Clinical manifestations of allergy to excipients can range from skin disorders to life-threatening systemic reactions. The aim of this study was to review the literature on allergy to pharmaceutical excipients and to record the IHRs described with various types of medications, specifically reactions due to the excipients contained in their formulations. The cases reported were sorted alphabetically by type of medication and excipient in order to obtain a list of the excipients most frequently involved for each type of medication.

Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines

“…In relation to excipients, it is important to highlight two points to take account before the administration of any vaccine or medication in general. First, it has been reported IHRs with unrelated products due to a common excipient [5]. As example, the case of a patient who suffered anaphylaxis after the intake of a laxative solution during bowel J Investig Allergol Clin Immunol 2021; Vol.…”

Hypersensitivity reactions and anaphylaxis to checkpoint inhibitor–monoclonal antibodies and desensitization

“…Whether some reactions to CPI-mabs can be attributable to excipients, such as PS20 or 80, is still unclear. 38…”

Delving Into COVID-19 Vaccination–Induced Anaphylaxis: Are mRNA Vaccines Safe in Mast Cell Disorders?

“…Besides PEG, the mRNA-1273 vaccine contains tromethamine, which is present in contrast media and other healthcare and cosmetic products and has been recently involved in an allergic reaction to gadolinium-based contrast media [7,8]. Thus, to assess whether a patient can safely receive one of these vaccines, a thorough clinical history including previous allergic reactions to drugs and self-care products is mandatory.…”